Shin Nippon Biomedical Laboratories, Ltd. (2395.T)
JPY 1537.0
(-1.22%)
JPY 1537.0
(-1.22%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 26.45 Billion | 25.09 Billion | 17.74 Billion | 15.11 Billion | 14.56 Billion | 15.65 Billion |
| Cost of Revenue | 12.16 Billion | 12.04 Billion | 8.06 Billion | 7.55 Billion | 6.94 Billion | 9.48 Billion |
| Gross Profit | 14.28 Billion | 13.04 Billion | 9.68 Billion | 7.55 Billion | 7.61 Billion | 6.17 Billion |
| Operating Expenses | 9.85 Billion | 7.8 Billion | 5.49 Billion | 5.02 Billion | 5.38 Billion | 5.34 Billion |
| Selling, General and Administrative Expenses | 8.11 Billion | 1.34 Billion | 1 Billion | 835.07 Million | 859.31 Million | 953.43 Million |
| Research and Development Expenses | 1.74 Billion | 683.06 Million | 425.07 Million | 392.23 Million | 400.85 Million | 339.81 Million |
| Other Expenses | - | 15.2 Million | 191.09 Million | 211.41 Million | 119.65 Million | 97.45 Million |
| Cost and Expenses | 22.28 Billion | 19.84 Billion | 13.55 Billion | 12.58 Billion | 12.33 Billion | 14.82 Billion |
| Operating Income | 4.16 Billion | 5.24 Billion | 4.19 Billion | 2.52 Billion | 2.22 Billion | 829.79 Million |
| Interest Expense | 138.78 Million | 125.06 Million | 126.64 Million | 184.86 Million | 235.01 Million | 377.79 Million |
| Income Tax Expense | 1.45 Billion | 1.7 Billion | 1.01 Billion | 497.79 Million | 414.54 Million | -308.08 Million |
| Earnings before Tax | 6.97 Billion | 7.75 Billion | 8.18 Billion | 4.17 Billion | 3.06 Billion | 1.65 Billion |
| Net Income | 5.53 Billion | 6.06 Billion | 7.12 Billion | 3.66 Billion | 2.55 Billion | 1.95 Billion |
| Earnings Per Share Basic | 132.86 | 145.57 | 171.21 | 87.96 | 61.26 | 46.85 |
| Earnings Per Share Diluted | 132.86 | 145.57 | 171.21 | 87.96 | 61.26 | 46.85 |
| Weighted Average Shares Outstanding | 41.63 Million | 41.63 Million | 41.63 Million | 41.63 Million | 41.63 Million | 41.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 41.63 Million | 41.63 Million | 41.63 Million | 41.63 Million | 41.63 Million | 41.63 Million |
| Gross Margin | 0.54 | 0.52 | 0.55 | 0.50 | 0.52 | 0.39 |
| EBIT Margin | 0.34 | 0.44 | 0.49 | 0.33 | 0.29 | 0.22 |
| Profit Margin | 0.21 | 0.24 | 0.40 | 0.24 | 0.18 | 0.12 |
| EBITDA | 8.98 Billion | 9.48 Billion | 9.48 Billion | 5.54 Billion | 4.52 Billion | 3.39 Billion |
| Earnings Before Tax Margin | 0.16 | 0.21 | 0.24 | 0.17 | 0.15 | 0.05 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 5.54 Billion | 26.45 Billion | 8.46 Billion | 6.1 Billion | 6.07 Billion | 5.8 Billion |
| Cost of Revenue | 2.52 Billion | 12.42 Billion | 3.72 Billion | 2.91 Billion | 2.91 Billion | 2.61 Billion |
| Gross Profit | 3.02 Billion | 14.02 Billion | 4.74 Billion | 3.18 Billion | 3.15 Billion | 3.19 Billion |
| Operating Expenses | 3.16 Billion | 9.85 Billion | 3.11 Billion | 2.99 Billion | 2.03 Billion | 1.96 Billion |
| Selling, General and Administrative Expenses | 3.16 Billion | - | 2.67 Billion | 2.17 Billion | 1.85 Billion | 1.96 Billion |
| Research and Development Expenses | 617 Million | - | 439.19 Million | 820 Million | 187.04 Million | 294.95 Million |
| Other Expenses | -617 Million | -8.45 Million | 51.74 Million | 39.27 Million | 35.63 Million | -135.11 Million |
| Cost and Expenses | 5.69 Billion | 22.28 Billion | 6.83 Billion | 5.91 Billion | 4.95 Billion | 4.57 Billion |
| Operating Income | -145.18 Million | 4.16 Billion | 1.62 Billion | 186.25 Million | 1.12 Billion | 1.22 Billion |
| Interest Expense | 40.55 Million | 138.78 Million | 41.92 Million | 34.16 Million | 25.74 Million | 36.94 Million |
| Income Tax Expense | 196.68 Million | 1.45 Billion | 323.82 Million | 292.54 Million | 280.49 Million | 559.87 Million |
| Earnings before Tax | 311.09 Million | 6.97 Billion | 2.03 Billion | 1.12 Billion | 1.87 Billion | 1.94 Billion |
| Net Income | 122.19 Million | 5.53 Billion | 1.73 Billion | 828.47 Million | 1.59 Billion | 1.37 Billion |
| Earnings Per Share Basic | 2.94 | - | 41.71 | 19.90 | 38.26 | 32.99 |
| Earnings Per Share Diluted | 2.94 | - | 41.71 | 19.90 | 38.26 | 32.99 |
| Weighted Average Shares Outstanding | 41.63 Million | 41.63 Million | 41.63 Million | 41.63 Million | 41.63 Million | 41.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 41.63 Million | 41.63 Million | 41.63 Million | 41.63 Million | 41.63 Million | 41.63 Million |
| Gross Margin | 0.55 | 0.53 | 0.56 | 0.52 | 0.52 | 0.55 |
| EBIT Margin | 0.06 | - | 0.26 | 0.19 | 0.31 | 0.33 |
| Profit Margin | 0.02 | 0.21 | 0.21 | 0.14 | 0.26 | 0.24 |
| EBITDA | 321.8 Million | - | 2.16 Billion | 1.16 Billion | 1.9 Billion | 1.91 Billion |
| Earnings Before Tax Margin | -0.03 | 0.16 | 0.19 | 0.03 | 0.18 | 0.21 |
6663
FRI
6425
CNXX
6994
LOM